Congenital Anomalies Treatment Market Share

  • Report ID: 2702
  • Published Date: Sep 03, 2024
  • Report Format: PDF, PPT

Congenital Anomalies Treatment Market Share

On the basis of geographical analysis, the global congenital anomalies treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Asia Pacific is poised to dominate majority revenue share by 2036, on the back of advancements in the healthcare sector, and rising healthcare expenditure across the region.

The market in the North America region is anticipated to gain the largest congenital anomalies treatment market share throughout the forecast period owing to the high prevalence of congenital diseases in infants in the region. As per the data by the Center of Disease Control and Prevention (CDC), one in every 33 babies or about 3% of all babies born in the United States suffer from birth defects each year.

Research Nester
Congenital-Anomalies-Treatment-Market-Share
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 2702
  • Published Date: Sep 03, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of congenital anomalies treatment is estimated at USD 164.33 million.

Congenital Anomalies Treatment Market size was valued at USD 158.5 million in 2023 and is likely to reach USD 284.41 million by 2036, registering around 4.6% CAGR during the forecast period i.e., between 2024-2036. Increasing prevalence of congenital anomalies will boost the market growth.

Asia Pacific is poised to dominate majority revenue share by 2036, on the back of advancements in the healthcare sector, and rising healthcare expenditure across the region.

The major players in the market are GlaxoSmithKline plc, Regeneron Pharmaceuticals, Inc., BioMarin Pharmaceutical Inc., Amgen Inc., Alexion Pharmaceuticals, Inc., Merck KGaA, Novartis International AG, Ipsen Pharma, Fresenius Kabi USA, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample